http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1260398-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568 |
| filingDate | 1969-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1972-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1260398-A |
| titleOfInvention | NEW 18-METHYL-5alpha-H-ANDROSTANES |
| abstract | 1,260,398. 18 - Methyl - 5α - H - androstanes. SCHERING A.G. 24 Feb., 1969 [24 Feb., 1968], No. 9800/69. Heading C2U. Novel steroids of the formula (in which R is H or acyl and A-B is -C(CH 3 )=CH- or -CH(α-OR<SP>1</SP>)-CH 2 -, R<SP>1</SP> being H or acyl) are prepared by reducing 18 - methyl - 17# - hydroxy - #<SP>4</SP> - androsten-3- one or an acylate thereof to the corresponding ring A saturated compounds and, if desired, dehydrogenating in the 1,2-position and, if desired, introducing a 1-methyl group into the #<SP>1</SP>-compound or, if desired, converting the #<SP>1</SP>- compound to a ring A saturated 1α-hydroxy or -acyloxy compound. Free 17-ols may be acylated and 17-acylates hydrolysed. 1,2- Dehydrogenation may be effected by 2-halogenation followed by dehydrohalogenation, or by a direct chemical or microbiological method. Introduction of a 1-methyl group may be effected via a 1,2-pyrazoline compound in known manner, or by converting the #<SP>1</SP> steroid to a 1-hydroxy-2-halo-ring A saturated steroid, eliminating the halogen, forming a 3-ketal, oxidizing to a 1-ketone, reacting this with a methyl Grignard reagent and treating the product with an acid. Introduction of a 1α- hydroxy group may be effected as indicated above or by epoxidizing the 1,2-double bond and then splitting the 1,2-epoxide, if necessary with protection of the 3-keto group. 17# - Hydroxy - 18 - methyl - #<SP>4</SP> - androsten-3- one is prepared from 3-methoxy-17#-acetoxy-18- methyl - #<SP>1,3,5(10),8,14</SP> - estrapentaene by catalytic hydrogenation to the corresponding 1,3,5(10, 8-tetraene, Birch reduction to 3-methoxy-17#- hydroxy - 18 - methyl - #<SP>2,5(10)</SP> - estradiene, acylation to the 17-acetate, cleavage to 17#- acetoxy - 18 - methyl - #<SP>5(10)</SP> - estren - 3 - one reduction to the corresponding 3#-ol (and the epimeric 3α-ol which is converted to the 3#-ol by conversion to 3α-mesyloxy-17#-acetoxy-18- methyl - #<SP>5(10)</SP>-estrene, conversion of this to 3# - formyloxy - 17# - acetoxy - 18 - methyl - #<SP>5(10)</SP>- estrene and hydrolysis of this), conversion with methylene iodide and Zn-Cu couple to 17#- acetoxy - 18 - methyl - 5,10# - methylene - 5#- estran-3#-ol, oxidation of this to the corresponding 3-one (which may be hydrolysed to 17#-hydroxy - 18 - methyl - 5,10# - methylene - 5# - estran- 3-one), and conversion of this to the required product, which may be acylated to give the 17 - acetate, the 17 - propionate and the 17- heptanoate. The novel steroids have anabolic and androgenic activity and may be made up into pharmaceutical compositions with suitable carriers. |
| priorityDate | 1968-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.